Clinical Trial Update: Tebentafusp in HLA-A*0201 Positive Previously Untreated Metastatic Uveal Melanoma [Phase 2]

View source ↗

Summary

This document provides an update on a Phase 2 trial of tebentafusp in HLA-A*0201 positive patients with previously untreated metastatic uveal melanoma. The stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uveal Melanoma

Drugs mentioned

• Tebentafusp (tebentafusp)

Snippet

Sponsor: Diwakar Davar | Conditions: Uveal Melanoma | Phase 2 | Status: RECRUITING